pubmed-article:20678438 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C0019169 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C0209738 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C0540694 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
pubmed-article:20678438 | lifeskim:mentions | umls-concept:C0449774 | lld:lifeskim |
pubmed-article:20678438 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:20678438 | pubmed:dateCreated | 2010-8-3 | lld:pubmed |
pubmed-article:20678438 | pubmed:abstractText | To investigate the resistance mutation patterns of hepatitis B virus(HBV) during adefovir dipivoxil (ADV) monotherapy or combination therapy after lamivudine(LAM) resistance. | lld:pubmed |
pubmed-article:20678438 | pubmed:language | chi | lld:pubmed |
pubmed-article:20678438 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20678438 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20678438 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20678438 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20678438 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20678438 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20678438 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20678438 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20678438 | pubmed:month | Jul | lld:pubmed |
pubmed-article:20678438 | pubmed:issn | 1007-3418 | lld:pubmed |
pubmed-article:20678438 | pubmed:author | pubmed-author:RAOT TTT | lld:pubmed |
pubmed-article:20678438 | pubmed:author | pubmed-author:HillL ELE | lld:pubmed |
pubmed-article:20678438 | pubmed:author | pubmed-author:TurkD RDR | lld:pubmed |
pubmed-article:20678438 | pubmed:author | pubmed-author:LiJingJ | lld:pubmed |
pubmed-article:20678438 | pubmed:author | pubmed-author:YingLiL | lld:pubmed |
pubmed-article:20678438 | pubmed:author | pubmed-author:GaoYing-tangY... | lld:pubmed |
pubmed-article:20678438 | pubmed:author | pubmed-author:DuZhiZ | lld:pubmed |
pubmed-article:20678438 | pubmed:author | pubmed-author:WuZhen-pingZP | lld:pubmed |
pubmed-article:20678438 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:20678438 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:20678438 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20678438 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20678438 | pubmed:pagination | 498-501 | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:meshHeading | pubmed-meshheading:20678438... | lld:pubmed |
pubmed-article:20678438 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20678438 | pubmed:articleTitle | [Resistance mutation patterns of hepatitis B virus in patients with suboptimal response to adefovir dipivoxil therapy after lamivudine resistance]. | lld:pubmed |
pubmed-article:20678438 | pubmed:affiliation | Third Central Hospital, Tianjin Medical University, Tianjin 300170, China. | lld:pubmed |
pubmed-article:20678438 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20678438 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:20678438 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |